Invesco Nasdaq Biotechnology ETF (IBBQ) Institutional Ownership $21.72 +0.13 (+0.58%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$7.75MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.12M Get IBBQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Invesco Nasdaq Biotechnology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IBBQ Institutional Buying and Selling by Quarter Invesco Nasdaq Biotechnology ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025CreativeOne Wealth LLC10,500$222K0.0%N/A0.580% 5/14/2025Partners Capital Investment Group LLP25,833$547K0.0%+100.0%1.427% 4/10/2025Breakwater Capital Group22,942$486K0.1%N/A1.233% 2/17/2025Citadel Advisors LLC10,709$230K0.0%-19.4%0.605% 2/14/2025Tower Research Capital LLC TRC28,061$604K0.0%+148.5%1.585% 2/13/2025Raymond James Financial Inc.41,261$888K0.0%N/A2.331% 2/13/2025Advisory Services Network LLC53,609$1.15M0.0%+5.8%3.029% 2/6/2025Raymond James Financial Inc.41,261$888K0.0%N/A2.331% 1/31/2025Partners Capital Investment Group LLP12,917$278K0.0%-50.0%0.730% 1/30/2025Strategic Financial Concepts LLC78,957$1.70M0.1%N/A4.461% Get the Latest News and Ratings for IBBQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 1/28/2025Strategic Financial Concepts LLC78,957$1.70M0.0%N/A4.461% 1/27/2025Mirae Asset Global Investments Co. Ltd.223,059$4.85M0.0%-14.1%12.602% 10/23/2024Mirae Asset Global Investments Co. Ltd.259,733$6.16M0.0%+22.7%15.935% 10/11/2024ORG Partners LLC1,067$25K0.0%N/A0.068% 5/14/2024Lake Street Advisors Group LLC12,917$286K0.0%N/A0.879% 4/25/2024Eudaimonia Partners LLC41,612$923K0.2%N/A2.831% 4/25/2024Eudaimonia Advisors LLC70,693$1.57M0.8%N/A4.809% 10/26/2023Mirae Asset Global Investments Co. Ltd.211,596$4.19M0.0%+2.4%25.190% 8/14/2023Partners Capital Investment Group LLP25,717$525K0.0%+100.4%3.062% 8/10/2023Mirae Asset Global Investments Co. Ltd.206,596$4.22M0.0%-0.2%24.595% 5/9/2023Tower Research Capital LLC TRC16,824$348K0.0%+18.4%1.753% 4/21/2023Capital Investment Advisory Services LLC11,001$228K0.0%-5.6%1.146% 2/9/2023Mirae Asset Global Investments Co. Ltd.207,096$4.37M0.0%-30.6%21.800% 2/8/2023Raymond James Financial Services Advisors Inc.29,366$619K0.0%+16.2%3.091% 2/8/2023Banco BTG Pactual S.A.37,266$786K0.4%-2.7%3.923% 11/15/2022Partners Capital Investment Group LLP12,806$242K0.0%N/A1.348% 11/15/2022Lake Street Advisors Group LLC12,806$242K0.0%N/A1.281% 11/15/2022Banco BTG Pactual S.A.38,307$725K0.4%-1.8%3.831% 11/10/2022Tower Research Capital LLC TRC37,649$712K0.0%-12.6%3.765% 10/26/2022Capital Investment Advisory Services LLC11,350$215K0.0%+6.1%1.135% 10/25/2022Raymond James Financial Services Advisors Inc.25,273$478K0.0%N/A2.527% 7/26/2022Mirae Asset Global Investments Co. Ltd.328,196$6.18M0.0%+4.7%29.303% 7/22/2022Capital Investment Advisory Services LLC10,700$201K0.0%+13.8%0.955% 5/3/2022Capital Investment Advisory Services LLC9,400$197K0.0%N/A0.752% 4/22/2022Apexium Financial LP17,299$410K0.2%-4.8%1.384% 2/10/2022Citigroup Inc.100,000$2.37M0.0%-75.0%8.621% 2/8/2022Bank of America Corp DE150,000$3.56M0.0%-62.5%12.931% 1/19/2022Apexium Financial LP18,178$431K0.2%N/A1.567% 11/15/2021Flow Traders U.S. LLC20,000$512K0.0%N/A1.117% 10/18/2021Clarius Group LLC18,752$480K0.0%N/A1.059% I was wrong about Trump (Ad)I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.Let me show you exactly what we’re doing to prepare.8/16/2021Bank of America Corp DE400,000$10.36M0.0%N/A20.408% 8/16/2021Morgan Stanley400,000$10.36M0.0%N/A20.408% 8/16/2021Credit Suisse AG400,000$10.36M0.0%N/A20.408% 8/12/2021JPMorgan Chase & Co.399,997$10.36M0.0%N/A19.802% (Data available from 1/1/2016 forward) IBBQ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IBBQ shares? During the previous two years, 13 institutional investors and hedge funds held shares of Invesco Nasdaq Biotechnology ETF. The most heavily invested institutionals were Mirae Asset Global Investments Co. Ltd. ($4.85M), Strategic Financial Concepts LLC ($1.70M), Eudaimonia Advisors LLC ($1.57M), Advisory Services Network LLC ($1.15M), Eudaimonia Partners LLC ($923K), Raymond James Financial Inc. ($888K), and Tower Research Capital LLC TRC ($604K).Learn more on Invesco Nasdaq Biotechnology ETF's institutional investors. Which institutional investors have been buying Invesco Nasdaq Biotechnology ETF's stock? Of the 12 institutional investors that purchased Invesco Nasdaq Biotechnology ETF's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Strategic Financial Concepts LLC ($157.91K), Raymond James Financial Inc. ($82.52K), Eudaimonia Advisors LLC ($70.69K), Mirae Asset Global Investments Co. Ltd. ($53.14K), Eudaimonia Partners LLC ($41.61K), Partners Capital Investment Group LLP ($25.80K), and Breakwater Capital Group ($22.94K). How much institutional buying is happening at Invesco Nasdaq Biotechnology ETF? Institutional investors have bought a total of 355,688 shares in the last 24 months. This purchase volume represents approximately $7.75M in transactions. Which of Invesco Nasdaq Biotechnology ETF's major shareholders have been selling company stock? The following institutional investors have sold Invesco Nasdaq Biotechnology ETF stock in the last 24 months: Mirae Asset Global Investments Co. Ltd. ($36.67K), Partners Capital Investment Group LLP ($12.92K), and Citadel Advisors LLC ($2.57K). How much institutional selling is happening at Invesco Nasdaq Biotechnology ETF? Institutional investors have sold a total of 52,164 shares in the last 24 months. This volume of shares sold represents approximately $1.12M in transactions. Related Companies BIB Major Shareholders LFSC Major Shareholders FTXH Major Shareholders JDOC Major Shareholders BIS Major Shareholders PTH Major Shareholders PSCH Major Shareholders BBH Major Shareholders PPH Major Shareholders IBB Major Shareholders This page (NASDAQ:IBBQ) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.